News
TURKU, FI / ACCESS Newswire / April 24, 2025 / Faron Pharmaceuticals Ltd. (AIM:FARN), a clinical-stage biopharmaceutical company developing novel immunotherapies, announces that new Phase II data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback